Is Avanos Medical Stock a Good Investment?
Avanos Medical Investment Advice | AVNS |
- Examine Avanos Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Avanos Medical's leadership team and their track record. Good management can help Avanos Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Avanos Medical's business and its evolving consumer preferences.
- Compare Avanos Medical's performance and market position to its competitors. Analyze how Avanos Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Avanos Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Avanos Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Avanos Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Avanos Medical is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Avanos Medical Stock
Researching Avanos Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 96.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avanos Medical has Price/Earnings To Growth (PEG) ratio of 2.29. The entity recorded a loss per share of 8.4. The firm had not issued any dividends in recent years.
To determine if Avanos Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Avanos Medical's research are outlined below:
| Avanos Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 687.8 M. Net Loss for the year was (392.1 M) with profit before overhead, payroll, taxes, and interest of 381.3 M. | |
| Avanos Medical has a frail financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are held by institutions such as insurance companies |
Avanos Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Avanos Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Avanos Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Avanos Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 679.47 M.Avanos Medical's profitablity analysis
The company has Profit Margin (PM) of (0.57) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.Determining Avanos Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Avanos Medical is a good buy. For example, gross profit margin measures Avanos Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Avanos Medical's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Avanos Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Avanos Medical. Check Avanos Medical's Beneish M Score to see the likelihood of Avanos Medical's management manipulating its earnings.
Basic technical analysis of Avanos Stock
As of the 22nd of March, Avanos Medical shows the mean deviation of 1.28, and Risk Adjusted Performance of (0.06). Avanos Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Avanos Medical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Avanos Medical is priced correctly, providing market reflects its regular price of 14.67 per share. Given that Avanos Medical has information ratio of (0.04), we suggest you to validate Avanos Medical's prevailing market performance to make sure the company can sustain itself at a future point.Avanos Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avanos Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avanos Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avanos Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Avanos Medical's Outstanding Corporate Bonds
Avanos Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avanos Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avanos bonds can be classified according to their maturity, which is the date when Avanos Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| AVATION CAP S Corp BondUS05351CAA53 | View | |
| US05352TAB52 Corp BondUS05352TAB52 | View | |
| AVANTOR FDG INC Corp BondUS05352TAA79 | View | |
| AVANGRID INC Corp BondUS05351WAB90 | View | |
| AVANGRID INC Corp BondUS05351WAC73 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Avanos Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Avanos Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 1.28 | |||
| Coefficient Of Variation | (1,444) | |||
| Standard Deviation | 1.88 | |||
| Variance | 3.54 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | 0.0026 | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 13.49 | |||
| Value At Risk | (2.62) | |||
| Potential Upside | 2.61 | |||
| Skewness | 0.6881 | |||
| Kurtosis | 4.62 |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.21) | |||
| Mean Deviation | 1.28 | |||
| Coefficient Of Variation | (1,444) | |||
| Standard Deviation | 1.88 | |||
| Variance | 3.54 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | 0.0026 | |||
| Treynor Ratio | (0.22) | |||
| Maximum Drawdown | 13.49 | |||
| Value At Risk | (2.62) | |||
| Potential Upside | 2.61 | |||
| Skewness | 0.6881 | |||
| Kurtosis | 4.62 |
Consider Avanos Medical's intraday indicators
Avanos Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Avanos Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Avanos Medical time-series forecasting models is one of many Avanos Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avanos Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Avanos Stock media impact
Far too much social signal, news, headlines, and media speculation about Avanos Medical that are available to investors today. That information is available publicly through Avanos media outlets and privately through word of mouth or via Avanos internal channels. However, regardless of the origin, that massive amount of Avanos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Avanos Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Avanos Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Avanos Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Avanos Medical alpha.
Avanos Medical Corporate Directors
| Patrick OLeary | Independent Director | Profile | |
| Julie Shimer | Independent Director | Profile | |
| William Hawkins | Independent Director | Profile | |
| Heidi Kunz | Independent Director | Profile |
Already Invested in Avanos Medical?
The danger of trading Avanos Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Avanos Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Avanos Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Avanos Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.